Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 6

1.

Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation.

Gimm O, Neuberg DS, Marsh DJ, Dahia PL, Hoang-Vu C, Raue F, Hinze R, Dralle H, Eng C.

Oncogene. 1999 Feb 11;18(6):1369-73.

2.

A single-nucleotide polymorphic variant of the RET proto-oncogene is underrepresented in sporadic Hirschsprung disease.

Griseri P, Sancandi M, Patrone G, Bocciardi R, Hofstra R, Ravazzolo R, Devoto M, Romeo G, Ceccherini I.

Eur J Hum Genet. 2000 Sep;8(9):721-4.

3.

The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.

Weinhaeusel A, Scheuba C, Lauss M, Kriegner A, Kaserer K, Vierlinger K, Haas OA, Niederle B.

Thyroid. 2008 Dec;18(12):1269-76. doi: 10.1089/thy.2008.0139.

PMID:
18976163
4.

Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma?

Baumgartner-Parzer SM, Lang R, Wagner L, Heinze G, Niederle B, Kaserer K, Waldhäusl W, Vierhapper H.

J Clin Endocrinol Metab. 2005 Nov;90(11):6232-6. Epub 2005 Aug 23.

PMID:
16118333
5.

Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population.

Ruiz A, Antiñolo G, Fernández RM, Eng C, Marcos I, Borrego S.

Clin Endocrinol (Oxf). 2001 Sep;55(3):399-402.

PMID:
11589684
6.

Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma.

Cebrian A, Lesueur F, Martin S, Leyland J, Ahmed S, Luccarini C, Smith PL, Luben R, Whittaker J, Pharoah PD, Dunning AM, Ponder BA.

J Clin Endocrinol Metab. 2005 Nov;90(11):6268-74. Epub 2005 Aug 9.

PMID:
16091499

Supplemental Content

Support Center